
欧洲医用胶原蛋白市场预测至 2028 年 - COVID-19 影响和区域分析(按来源(牛、猪等)、产品(明胶、水解胶原蛋白、天然胶原蛋白等)和应用(伤口护理、骨移植、组织)支架、软骨修复、止血剂、诊断、血管移植物等)
No. of Pages: 150 | Report Code: TIPRE00024541 | Category: Life Sciences
No. of Pages: 150 | Report Code: TIPRE00024541 | Category: Life Sciences
医用胶原蛋白广泛应用于伤口愈合、组织工程、重建手术、骨移植、和整容手术。它是具有低免疫原性的生物相容性材料。胶原蛋白具有良好的止血特性,促进伤口愈合。胶原蛋白用于细胞培养,因为它支持晶格结构和细胞结合域中的细胞增殖。因此胶原蛋白作为生物材料广泛应用于医疗行业。
正在研究一种含有胶原蛋白的医疗产品来治疗多种疾病。由于其临床和消费者的认可,它被广泛用作医疗材料。基于胶原蛋白的医疗产品,如生物假体心脏瓣膜、动脉替代物、外科手术中使用的缝合线和伤口敷料已被广泛采用。因此,正在进行多项研究以开发新的基于胶原蛋白的医疗产品。例如,2020 年,MPM Medical 启动了 CoMatryx 外科牛胶原蛋白研究。 CoMatryx 外科胶原蛋白粉是一种由 100% I 型牛胶原蛋白制成的软组织修复产品。此外,正在进行研究以发现用于医用生物材料的胶原蛋白的新来源。例如,研究“用于医用生物材料的罗非鱼(Oreochromis aureus)胶原蛋白”发表于 2018 年。研究人员研究了罗非鱼皮作为胶原蛋白替代来源在医用生物材料中应用的潜力。因此,基于胶原蛋白的医疗产品的研究活动的增加可能会在预测期内推动市场的增长。此外,医用胶原蛋白市场的各个参与者正在开发和推出新产品,以扩大其地理范围和能力,以满足许多客户的需求。因此,医用胶原蛋白产品和审批监管机构的不断进步是进一步推动医用胶原蛋白市场增长的因素。
欧洲的 COVID-19 病例数量不断增加自爆发以来。然而,由于 COVID-19 的爆发,欧洲的健康和保健市场正在稳步增长。胶原蛋白肽是疫情期间广受欢迎的产品之一。欧洲人正在寻找不同的自然方法来保持健康和增强免疫系统。因此,人们越来越关注胶原蛋白肽如何增强维生素和保健品,并在大流行期间帮助人们保持健康。此外,由于保持社交距离的做法,消费者的日常生活(包括美容和护肤)正在发生变化。这导致对可在家使用的营养化妆品的需求增加。这可能会推动护肤胶原蛋白产品的增长。因此,COVID-19对欧洲医用胶原蛋白市场产生了积极影响。
欧洲医用胶原蛋白市场按来源分为牛、猪等。牛类细分市场在 2020 年占据最大的市场份额,预计在预测期内复合年增长率最高。
欧洲医用胶原蛋白市场按产品细分分为明胶、水解胶原蛋白、天然胶原蛋白等。明胶细分市场在 2020 年占据最大市场份额,预计在预测期内复合年增长率最高。
根据应用,欧洲医用胶原蛋白市场进行细分止血剂、血管移植物、组织支架、软骨修复、伤口护理、骨移植、诊断等。伤口护理细分市场在 2020 年占据最大市场份额。然而,预计骨移植细分市场在预测期内的复合年增长率最高。
与本报告相关的一些主要和二手来源欧洲医用胶原蛋白市场包括欧洲药品管理局(EMA)、欧盟(EU)和西班牙国家卫生系统(SNHS)。
p>
Strategic insights for Europe Medical Collagen involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 175.11 Million |
Market Size by 2028 | US$ 255.72 Million |
Global CAGR (2021 - 2028) | 5.6% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 来源
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Medical Collagen refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Medical Collagen Market is valued at US$ 175.11 Million in 2021, it is projected to reach US$ 255.72 Million by 2028.
As per our report Europe Medical Collagen Market, the market size is valued at US$ 175.11 Million in 2021, projecting it to reach US$ 255.72 Million by 2028. This translates to a CAGR of approximately 5.6% during the forecast period.
The Europe Medical Collagen Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Medical Collagen Market report:
The Europe Medical Collagen Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Medical Collagen Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Medical Collagen Market value chain can benefit from the information contained in a comprehensive market report.